Last reviewed · How we verify
PRBC and cell saver Transfusion — Competitive Intelligence Brief
marketed
Biologic
Live · refreshed every 30 min
Target snapshot
PRBC and cell saver Transfusion (PRBC and cell saver Transfusion) — The University of Texas Health Science Center, Houston.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| PRBC and cell saver Transfusion TARGET | PRBC and cell saver Transfusion | The University of Texas Health Science Center, Houston | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- PRBC and cell saver Transfusion CI watch — RSS
- PRBC and cell saver Transfusion CI watch — Atom
- PRBC and cell saver Transfusion CI watch — JSON
- PRBC and cell saver Transfusion alone — RSS
Cite this brief
Drug Landscape (2026). PRBC and cell saver Transfusion — Competitive Intelligence Brief. https://druglandscape.com/ci/prbc-and-cell-saver-transfusion. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab